Literature DB >> 29627955

T wave positivity in lead aVR is associated with mortality in patients with cardiac resynchronization therapy.

Yahya Kemal İçen1, Yurdaer Dönmez2, Hasan Koca2, Mehmet Uğurlu2, Mevlüt Koç2.   

Abstract

PURPOSE: Positive T wave polarity in lead aVR (TPaVR) is associated with a poor prognostic indicator in patients with heart failure reduce ejection fraction (HFrEF). Our aim was to investigate the relationship between positive TPaVR and mortality in patients with cardiac resynchronization therapy defibrillator (CRT-D).
METHODS: We included retrospectively 224 HFrEF patients with CRT-D in sinus rhythm. Laboratory, electrocardiographic (ECG), and echocardiographic data were recorded. T wave polarity was measured in lead DI, DII, and aVR from surface ECG.
RESULTS: The patients were divided as living and deceased. They followed for 2.5 ± 0.9 years. Thirty-three patients (14.7%) died. Six patients (18.2%) were TPaVR positive before CRT-D and this number increased to 22 (66.6%) after CRT-D in the deceased group. Pulse (p = 0.049), hyperlipidemia (p = 0.022), and NT-proBNP levels were higher in the deceased group (p = 0.001). TPaVR before CRT-D (p < 0.001) and TPaVR after CRT-D (p < 0.001) were significantly positive in the deceased group. Positive TPaVR after CRT-D was the only independent predictor for mortality in binominal logistic regression analysis (OR 1.211, 95% CI 1.105-1.328, p < 0.001).
CONCLUSIONS: In CRT-D patients, a positive TPaVR in surface ECG may be a strong mortality indicator.

Entities:  

Keywords:  Cardiac resynchronization; ECG; Lead aVR; Mortality

Mesh:

Year:  2018        PMID: 29627955     DOI: 10.1007/s10840-018-0364-9

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  21 in total

1.  2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA).

Authors:  Michele Brignole; Angelo Auricchio; Gonzalo Baron-Esquivias; Pierre Bordachar; Giuseppe Boriani; Ole-A Breithardt; John Cleland; Jean-Claude Deharo; Victoria Delgado; Perry M Elliott; Bulent Gorenek; Carsten W Israel; Christophe Leclercq; Cecilia Linde; Lluís Mont; Luigi Padeletti; Richard Sutton; Panos E Vardas
Journal:  Europace       Date:  2013-06-24       Impact factor: 5.214

Review 2.  Clinical utility of aVR-The neglected electrocardiographic lead.

Authors:  Dmitriy Kireyev; Mikhail V Arkhipov; Stephen T Zador; Joseph A Paris; William E Boden
Journal:  Ann Noninvasive Electrocardiol       Date:  2010-04       Impact factor: 1.468

3.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

Authors:  Piotr Ponikowski; Adriaan A Voors; Stefan D Anker; Héctor Bueno; John G F Cleland; Andrew J S Coats; Volkmar Falk; José Ramón González-Juanatey; Veli-Pekka Harjola; Ewa A Jankowska; Mariell Jessup; Cecilia Linde; Petros Nihoyannopoulos; John T Parissis; Burkert Pieske; Jillian P Riley; Giuseppe M C Rosano; Luis M Ruilope; Frank Ruschitzka; Frans H Rutten; Peter van der Meer
Journal:  Eur J Heart Fail       Date:  2016-05-20       Impact factor: 15.534

4.  Diagnostic significance for coronary artery disease of abnormal Q waves in the "lateral" electrocardiographic leads.

Authors:  R A Warner; N E Hill; S Mookherjee; H Smulyan
Journal:  Am J Cardiol       Date:  1986-09-01       Impact factor: 2.778

5.  T-wave reversal in the augmented unipolar right arm electrocardiographic lead is associated with increased risk of sudden death.

Authors:  Derek Phan; Kumar Narayanan; Audrey Uy-Evanado; Carmen Teodorescu; Kyndaron Reinier; Harpriya Chugh; Karen Gunson; Jonathan Jui; Sumeet S Chugh
Journal:  J Interv Card Electrophysiol       Date:  2015-12-01       Impact factor: 1.900

6.  A randomized double-blind comparison of biventricular versus left ventricular stimulation for cardiac resynchronization therapy: the Biventricular versus Left Univentricular Pacing with ICD Back-up in Heart Failure Patients (B-LEFT HF) trial.

Authors:  Giuseppe Boriani; Wolfgang Kranig; Erwan Donal; Leonardo Calo; Michela Casella; Nicolas Delarche; Ignacio Fernandez Lozano; Gerardo Ansalone; Mauro Biffi; Eric Boulogne; Christophe Leclercq
Journal:  Am Heart J       Date:  2010-06       Impact factor: 4.749

7.  Positive T wave in lead aVR as an independent predictor for 1-year major adverse cardiac events in patients with first anterior wall ST-segment elevation myocardial infarction.

Authors:  Akihiro Kobayashi; Naoki Misumida; Shunsuke Aoi; Yumiko Kanei
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-02-16       Impact factor: 1.468

8.  The effect of cardiac resynchronization on morbidity and mortality in heart failure.

Authors:  John G F Cleland; Jean-Claude Daubert; Erland Erdmann; Nick Freemantle; Daniel Gras; Lukas Kappenberger; Luigi Tavazzi
Journal:  N Engl J Med       Date:  2005-03-07       Impact factor: 91.245

9.  The prognostic value of discordant T waves in lead aVR: A simple risk marker of sudden cardiac arrest in ischemic cardiomyopathy.

Authors:  Salah S Al-Zaiti; James A Fallavollita; John M Canty; Mary G Carey
Journal:  J Electrocardiol       Date:  2015-06-25       Impact factor: 1.438

10.  Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study.

Authors:  Alfred E Buxton; Kerry L Lee; Gail E Hafley; Luis A Pires; John D Fisher; Michael R Gold; Mark E Josephson; Michael H Lehmann; Eric N Prystowsky
Journal:  J Am Coll Cardiol       Date:  2007-09-04       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.